Breaking News
Top News
-
Neurocrine Biosciences (NBIX) Announces First Presentation of New Two-Year Data From Phase 3 CAHtalyst® Adult Study
-
RBC Capital Lifts PT BioCryst Pharmaceuticals (BCRX) as Part of Q1 2026 Results Preview in Biotech
-
Kiniksa Pharmaceuticals International (KNSA) Announces Q1 2026 Financial Results
-
ANI Pharmaceuticals (ANIP) Announces Launch of Pimozide Tablets 1 mg and 2 mg
-
Jefferies Downgrades Amphastar Pharmaceuticals (AMPH), Cites Lack of Meaningful Upside Catalysts
-
Is Boston Scientific Corporation (BSX) One of the Best Medical Device Stocks to Invest in Right Now?
-
Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 Software
-
BTIG Remains Bullish on DexCom, Inc. (DXCM)
-
Truist Cuts PT on Stryker Corporation (SYK) as Part of Fiscal Q1 Results Preview in MedTech
-
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings
-
Medtronic plc (MDT) Receives the CE Mark for the Stealth AXiS™ Surgical System
-
Rothschild & Co Redburn Downgrades Insulet Corporation (PODD), Cites “Eroding” Product Moats and Distribution
-
Why GE HealthCare Technologies (GEHC) is One of the Best Medical Device Stocks to Invest in Right Now
-
Truist Cuts PT on iRhythm Technologies (IRTC) as Part of Fiscal Q1 Results Preview in MedTech
-
UBS Initiates Coverage of Amneal Pharmaceuticals (AMRX) With a Bullish Outlook
-
Canaccord Cuts PT on Smith & Nephew (SNN) Ahead of Fiscal Q1 Results
-
Is Tronox Holdings plc (TROX) One of the Best Performing Small Cap Stocks So Far in 2026?
-
Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program
-
Why Climb Bio (CLYM) is One of the Best Performing Small Cap Stocks So Far in 2026
-
Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)
2026-02-05













